down on low volume with great news on how they plan to add to revenue yet OSIR is up on a management change
I realize management could care less around the price move today but all this poor price action really sends a bad message to prospective share buyers.
Who would buy seeing the price action over the past couple of days with the news the company provided???
Big position being unloaded. You have to be an idiot to be opening a short position at this price and this time. You can't use a clinical drug development measuring stick to size up a wound care player. Wound care is still the Wild West and Petit is the right cowboy. He's kicked OSIR butt in time to market and getting insurance coverage. It only a matter of time before this takes off.
And mdxg is more than just a wound care company,,,the amniofix is another new territory to disrupt. Speaking of disruptive, mdxg has blown apart the wound care market and will hit numbers with 2 percent penetration according to last conference call.